Click here to fill out a contact form or call us at 847-419-9100 if you are interested in any of the studies below.

Inflammatory Rosacea Study
Is INFLAMMATORY ROSACEA controlling your life?
We are looking for men and women, 16 years of age and older to participate in a clinical research study for inflammatory rosacea. If you currently suffer from moderate redness and can count at least 10 pustules and papules (red bumps) on your face, you may be eligible to receive study related treatment.
Qualified participants will receive:

  • Skin evaluations by a board certified dermatologist at no cost
  • Study medication for 12 weeks
  • Compensation for time and travel


Actinic Keratoses Study -
Have you been diagnosed with Actinic Keratoses?
If you are over 18 years old, have Actinic Keratoses (AK), and can count at least 4 AK lesions on each hand and/or forearm, you may qualify to participate in a clinical research trial using photodynamic therapy (PDT) and a topical medication or placebo solution (a solution with no medically active ingredients).This is a 12 (twelve) week long study and requires 5 (five) visits to our office.

Qualified participants will receive:

  • Skin evaluations by a board certified dermatologist
  • Study medication and treatment
  • Compensation for time and travel


Psoriasis Study-
PSORIASIS has made its mark on you. Here’s a chance to make yours. Join our psoriasis registry.

PSOLAR is looking for 8,000 volunteers to participate in an eight year registry to observe and collect information from patients with moderate-to-severe psoriasis. No medications will be administered and you will not have to change your current psoriasis treatment or care.

You may qualify if you:
  • Are a male or female
  • Are at least 18 years of age
  • Have been diagnosed with psoriasis
  • Are willing to participate in follow-up visits every 6 months
 
 
Rosacea Study-
Does your sensitive skin make it difficult for you to treat your rosacea?

We are looking for men and women, 18 years of age and older, who have a sensitivity towards metronidazole gel, 1%, to participate in a clinical research study for mild to moderate rosacea. If you currently suffer from mild to moderate redness and have previously experienced irritation, redness, or dryness after using metronidazole gel, 1%, on your face, you may be eligible to receive study related treatment.

Qualified participants will receive:
  • skin evaluations by a board certified dermatologist
  • an FDA approved study medication for 8 weeks